Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TK-90 for 5-FU Induced Mucositis in Colorectal Cancer
NCT05669521Phase 2Unknown
- Sponsor
- Tosk, Inc.
- Start
- Jun 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in mucositis comparing TK112690 Arm with Placebo Arm (2 arms). Primary endpoint: Mucositis at 8 weeks. Status: unknown.
02
Drugs
TK-112690
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT05669521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05669521.